Novartis | NVS - Pendapatan Penjualan

Harga Saham
159.23
Perubahan Harian
-1.76 -1.09%
Bulanan
1.47%
Tahunan
37.78%
Q1 Perkiraan
164.51




Penjualan Perubahan Tanggal
AbbVie USD 16.62B 840M 2025-12
Amgen USD 9.9B 340M 2025-12
AstraZeneca USD 15.5B 313M 2025-12
Bausch Health Companies USD 2.8B 120M 2025-12
Biogen USD 2.28B 250M 2025-12
Bristol-Myers Squibb USD 12.5B 300M 2025-12
Canopy Growth CAD 66.68M 5.45M 2025-09
Corcept Therapeutics USD 202.12M 5.48M 2025-12
Drreddys Laboratories INR 87.27B 1.82B 2025-12
Eli Lilly USD 19.3B 1.7B 2025-12
Gilead Sciences USD 7.93B 130M 2025-12
GlaxoSmithKline GBP 8.62B 73M 2025-12
Glaxosmithkline GBP 11.52B 3.54B 2025-09
J&J USD 24.6B 610M 2025-12
Merck USD 16.4B 880M 2025-12
Novartis USD 13.91B 144M 2025-09
Novartis USD 14.36B 478M 2025-09
Pacira USD 196.87M 17.35M 2025-12
Perrigo USD 1.11B 70M 2025-12
Pfizer USD 17.58B 880M 2025-12
Phibro Animal Health USD 309.26M 48.83M 2024-12
Prestige Brands USD 283.44M 9.34M 2025-12
Roche Holding CHF 15.65B 274.5M 2025-12
Sanofi EUR 11.3B 1.13B 2025-12
Sanofi EUR 12.2B 3.19B 2025-12
Supernus Pharmaceuticals USD 211.6M 19.5M 2025-12
Zoetis USD 2.4B 0 2025-12